Come up with a name for your new list and we'll add to it:
Conforma Therapeutics was acquired by
Biogen IDEC on May 22, 2006.
Conforma Therapeutics is focused on the design and development of novel drugs for the selective treatment of cancer. Conforma developed drugs that target the cellular HSP90 family of molecular "chaper…